Polymarket's international prediction market platform experienced an outage after a third-party data provider was hacked, leading to unauthorized withdrawals from user wallets. The company paused trading on the platform, fixed the issue, and plans to refund affected users. It has also reported the incident to U.K. law enforcement, as the third-party provider operates there. The domestic platform remained operational, and trading is set to resume soon, just before the U.S. midterm elections when trading volumes are expected to rise.
Polymarket's recent platform outage is presented here with Pluang's market data for context. For readers following US stocks, 93 of 150 priced shares rose while 57 fell. Notable movers include CAT at USD 641.49 with a -10.08% change, FIRY at USD 13.38 with an +8.87% change, and KGC at USD 21.29 with a -7.35% change, as of Oct 30, 2026 02:01 WIB.
SAP, a global enterprise software leader, will merge its North Texas operations into a new office in Addison, Texas, relocating about 1,000 employees from Plano and Allen. The new Spectrum Center location will house business operations, software deve...
Ipsos has appointed Mitch Barns as Chairman and CEO for the Americas region, effective November 2, 2026. Barns brings extensive leadership experience from his previous roles as Global CEO of Nielsen and CEO of The Opus Group, positioning him to drive...
UPS plans to handle nearly 70% of holiday packages through automated sorting, using robots and RFID tags to improve efficiency and reduce labor costs. CEO Carol Tomé highlighted that while package volume is intentionally reduced, especially from Amaz...
Mastercard reported robust Q3 results with 14% revenue growth and 21% earnings per share growth, driven by strong operating leverage. Management reaffirmed its guidance and expects continued outperformance. The stock reached a new all-time high, supp...
Cartesian Therapeutics maintains a 'Buy' rating due to progress in its Descartes-08 cell therapy programs, with pivotal phase 3 trial results for Myasthenia Gravis expected in early 2027 and a potential regulatory filing mid-year. The company is also...
